Lincoln Pharmaceuticals fundamental analysis

LINCOLN

631.45

15.80 (2.57%)
Last updated on 26 Feb, 2026 | 10:05 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Lincoln Pharmaceuticals Fundamentals

P/E Ratio

13.95

P/B Ratio

1.65

Div. Yield

0.29

Sector P/E

63.12

Sector P/B

2.79

Sec. Div. Yield

0.57

Lincoln Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 13.95, compared to the sector average of 63.12. Its P/B Ratio stands at 1.65, while the sector’s is 2.79. In terms of returns, the stock offers a Dividend Yield of 0.29%, which is than the sector’s 0.57%.

Lincoln Pharmaceuticals Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Average

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Lincoln Pharmaceuticals reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost